GLP-1 receptor agonist semaglutide ameliorates motor deficits and tau pathology in the rTg4510s mouse model

作者：Mengwei Zhang, Wan-Yi Zhou, Xinyi Li, Zhiheng Xu, Hua-Mei Lin, Yilin Tang, Jue Zhao, Chen Chen, Fengtao Liu, Yimin Sun, Chuantao Zuo, Jian-Jun Wu, Jian Wang, Wenbo Yu · 发表于：Neuropharmacology · 年份：2025 · DOI：10.1016/j.neuropharm.2025.110659 · 被引用次数：4 · 研究领域：Alzheimer's disease research and treatments、Diabetes Treatment and Management、Parkinson's Disease Mechanisms and Treatments